Tag: strategies

Sydney, Australia, June 17, 2026 (GLOBE NEWSWIRE) -- Australian superannuation regulations require self-managed super funds to maintain a documented investment strategy that covers asset allocation, liquidity, diversification, and both income and capital objectives. The Australian Taxation Office mandates that the strategy be reviewed at least annually. For trustees building that strategy around delivering monthly income, the income side of the portfolio will be reviewed closely. The latest ATO data shows the SMSF sector now holds A$1.06 trillion in assets across 663,867 funds, with cash and term deposit allocations falling to 16.3% of holdings, a record low, as trustees look beyond traditional cash products. To learn mroe visit https://termplus.com.au/term-account-smsf/

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Ear Health Market size & share revenue was valued at approximately USD 10.12 Billion in 2025 and is expected to reach USD 10.82 Billion in 2026 and is expected to reach around USD 16.87 Billion by 2035, at a CAGR of 5.7% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Sonova Holdings AG, GN Store Nord A/S, William Demant Holdings A/S, Starkey Laboratories Inc., WS Audiology, Cochlear Limited, MED-EL, Eargo Inc., Audina Hearing Instruments Inc., Rion Co. Ltd and others.

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at approximately USD 1.14 Billion in 2025 and is expected to reach USD 1.23 Billion in 2026 and is expected to reach around USD 2.27 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Bio-Rad Laboratories Inc., Oxford Gene Technology (Sysmex), Abnova Corporation, Empire Genomics LLC, MetaSystems Group and others.